+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Verapamil"

Calcium Channel Blockers - Global Strategic Business Report - Product Thumbnail Image

Calcium Channel Blockers - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
Anti-Ischemic Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Ischemic Agents - Global Strategic Business Report

  • Report
  • April 2025
  • 94 Pages
  • Global
From
Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Anti-Hypertensive Drugs Market Report 2025 - Product Thumbnail Image

Anti-Hypertensive Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Calcium Channel Blocker Market Report 2025 - Product Thumbnail Image

Calcium Channel Blocker Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Verapamil is a calcium channel blocker used to treat high blood pressure, angina, and certain types of arrhythmia. It is a commonly prescribed cardiovascular drug, and is available in both oral and injectable forms. Verapamil works by blocking the influx of calcium into the cells of the heart and blood vessels, which helps to relax the muscles and reduce the workload of the heart. It is also used to treat cluster headaches and migraine headaches. Verapamil is available in both generic and brand-name formulations. The brand-name versions include Calan, Isoptin, and Verelan. Generic versions are available from a variety of manufacturers. In the Verapamil market, there are several major players, including Pfizer, Novartis, and Mylan. Other companies in the market include Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less Read more